The article offers information about various developments related to breast cancer. A new breast cancer treatment will be developed by Schering AG and AstraZeneca PLC together. GlaxoSmithKline PLC is seeking an approval from the U.S. Food and Drug Administration for the marketing of its drug Tykerb in combination with Xeloda. The progression of advanced breast cancer could be delayed with the addition of Xeloda to the combination of Herceptin and Sanofi Aventis.
Processing Request
No Comments.